Miriam Metzinger submits: Stocks discussed in the lightning round session of Jim Cramer’s Mad Money TV program, Friday March 30. Click on a stock ticker for more analysis:
Supervalu (NYSE:SVU):' ... is doing really well.'
Safeway (NYSE:SWY): ' ... my personal favorite, which is SWY, because they've got the Blackhawk card - which is the prepaid card - that I think is taking America by storm!'
ValueClick (VCLK): 'VCLK is worth $35, if Doubleclick is worth $2 billion... It's at $26 right now. So, I would tell you that VCLK has just hit the ball out of the park repeatedly ... It grows at 20%. It sells at 30x earnings. Let's pull the trigger on VCLK, just based on the Doubleclick perspective deal.'
American Capital Strategies (NASDAQ:ACAS): ' ... it does specialty finance, and it's very hard to figure out where they're invested in... It's a little bit of a black box, but they have done a very good job over time ... I am no longer critical ... 8% yield... (buzzer sounds)... ACAS is a good deal.'
Allscripts Healthcare Solutions (NASDAQ:MDRX): 'We have liked this stock for a long time. Anything that makes the medical system more friendly, more inexpensive... is a win ... I am reiterating buy right here.'
United Technologies (NYSE:UTX): 'I like UTX very much. I think that George Dane is a great CEO. I want to pull the trigger.'
Goodyear Tire (NYSE:GT): ' ... is fabulous here at $31. They did the pension thing ... I want to keep buying that stock.'
NYSE (NYSE:NYX): 'Wow! The deal closes April 4th. It's at $93.'
Seeking Alpha publishes a summary of Jim Cramer's stock picks every day including: Mad Money Recap, Lightning Round, Stop Trading and Wall Street Confidential
Ahold (AHO): ' 52-week high. This is a worst-of-breed company that's trying to come back from a series of tragic errors....I would take my profits here.'
Blockbuster (BBI): 'Look, Antioco (former CEO) is the guy who brought me to the stock... I have been suspicious. I have been skeptical... But he left! ... And I'm a seller of BBI! Sell, sell, sell!'
Acadia Pharmaceuticals (NASDAQ:ACAD): ' ... it is making a gigantic, gigantic comeback, because of the schizophrenia drug. That's a very hard illness to deal with, very hard to cure. That's why I am saying take the gain! Sell, sell, sell.'
Get Cramer's Picks by email -- it's free and takes only a few seconds to sign up.
Seeking Alpha is not affiliated with CNBC, Jim Cramer or TheStreet.com